These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 14384884)
1. Plasma thromboplastin component (PTC) deficiency produced by prolonged administration or prothrombopenic anticoagulants. SISE HS; KIMBALL DM; ADAMIS D Proc Soc Exp Biol Med; 1955 May; 89(1):81-3. PubMed ID: 14384884 [No Abstract] [Full Text] [Related]
2. Plasma thromboplastin component (PTC), a hitherto unrecognized blood coagulation factor; case report of PTC deficiency. WHITE SG; AGGELER PM; GLENDENING MB Blood; 1953 Feb; 8(2):101-24. PubMed ID: 13018345 [No Abstract] [Full Text] [Related]
3. Plasma thromboplastin component (PTC) deficiency; a new disease resembling hemophilia. AGGELER PM; WHITE SG; GLENDENING MB; PAGE EW; LEAKE TB; BATES G Proc Soc Exp Biol Med; 1952 Apr; 79(4):692-4. PubMed ID: 14920537 [No Abstract] [Full Text] [Related]
4. AN INVESTIGATION OF THE HEMORRHAGIC DIATHESIS IN PATIENTS RECEIVING COUMARIN AND INDANEDIONE ANTICOAGULANTS. BAUGH CW Can Med Assoc J; 1965 Jan; 92(3):116-20. PubMed ID: 14232183 [TBL] [Abstract][Full Text] [Related]
5. Use of purified prothrombin in the study of hemophilia and plasma thromboplastin component (PTC) deficiency. JOHNSON SA; SEEGERS WH J Appl Physiol; 1954 Jan; 6(7):429-36. PubMed ID: 13117776 [No Abstract] [Full Text] [Related]
6. [Hemophilia B; two cases of hereditary hemophilia due to a deficiency of a new clotting factor (Christmas factor)]. CRAMER R; FLUCKIGER P; GASSER C; KOLLER F; LOELIGER A; MATTER M Acta Haematol; 1953 Aug; 10(2):64-76. PubMed ID: 13091697 [No Abstract] [Full Text] [Related]
7. [STUDIES ON FACTOR IX ACTIVITY. I. RELATION BETWEEN SERUM THROMBOPLASTIN GENERATION TEST AND WHOLE BLOOD CLOTTING TIME, WITH SPECIAL REFERENCE TO THE MODE OF ACTION OF FACTOR IX AND CONTACT FACTOR]. MATSUOKA T Nihon Ketsueki Gakkai Zasshi; 1963 Apr; 26():231-43. PubMed ID: 14043489 [No Abstract] [Full Text] [Related]
8. [Congenital deficiency of factor IX (Christmas, PTC); hemophilia B]. HULE V; NESPURKOVA M Vnitr Lek; 1955 Mar; 1(3):179-82. PubMed ID: 13247730 [No Abstract] [Full Text] [Related]
9. Plasma thromboplastin component: influence of coumarin compounds and vitamin K on its activity in serum. NAEYE RL Proc Soc Exp Biol Med; 1956 Jan; 91(1):101-4. PubMed ID: 13297720 [No Abstract] [Full Text] [Related]
10. BLOOD COAGULATION. VII. COAGULATION II. DUGDALE M Memphis Mid South Med J; 1963 Jan; 38():19-22. PubMed ID: 14087826 [No Abstract] [Full Text] [Related]
11. Hemorrhagic diathesis due to PTC (plasma thromboplastin component) deficiency. LEWIS JH; FERGUSON JH Proc Soc Exp Biol Med; 1953 Mar; 82(3):445-8. PubMed ID: 13047427 [No Abstract] [Full Text] [Related]
12. Haemorrhagic diathesis due to a circulating anticoagulant investigated by the thromboplastin generation test. EVANS DM J Clin Pathol; 1955 May; 8(2):168-72. PubMed ID: 14367554 [No Abstract] [Full Text] [Related]
13. THROMBOPLASTIC ACTIVITY OF HUMAN SALIVA IN PATIENTS UNDER PROLONGED ANTICOAGULATION THERAPY. DOKU HC; TAYLOR RG; SISE HS; BECKER R J Dent Res; 1964; 43():323-30. PubMed ID: 14159035 [No Abstract] [Full Text] [Related]
14. [Modification of coagulation factor IX by hydroxycoumarin and phenylindandione derivatives]. EGLI H; SCHNEIDER W Thromb Diath Haemorrh; 1961 Sep; 6():331-8. PubMed ID: 13889446 [No Abstract] [Full Text] [Related]
16. PLASMA THROMBOPLASTIN COMPONENT (PTC) DEFICIENCY: A CASE REPORT. IDA M; TANAKA M Shonika Kiyo; 1963; 9():297-301. PubMed ID: 14112922 [No Abstract] [Full Text] [Related]
17. [Hemophilic syndrome of associated antihemophilic globulin and plasma thromboplastin component deficiencies]. BARBAGALLO-SANGIORGI G; CAJOZZO A Haematologica; 1955; 40():391-422. PubMed ID: 13384874 [No Abstract] [Full Text] [Related]
18. MODIFICATIONS OF THE COAGULATION MECHANISM DURING PREGNANCY. PHILLIPS LL Mod Trends Hum Reprod Physiol; 1963; 15():190-204. PubMed ID: 14115154 [No Abstract] [Full Text] [Related]
19. The levels of factors II, VII, IX and X by antibody neutralization techniques in the plasma of patients receiving phenindione therapy. Denson KW Br J Haematol; 1971 Jun; 20(6):643-8. PubMed ID: 5089955 [No Abstract] [Full Text] [Related]
20. Hemorrhagic disease with circulating inhibitors of blood clotting: anti-AHF and anti-PTC in eight cases. ARENDS T; FERGUSON JH; LEWIS JH Blood; 1956 Sep; 11(9):846-55. PubMed ID: 13355894 [No Abstract] [Full Text] [Related] [Next] [New Search]